Bisphenol A (BPA) and its brominated derivative tetrabromobisphenol A (TBBPA) are high production volume chemicals utilized in the manufacture of various consumer products.
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INTRODUCTION
Bisphenol A (BPA) and its brominated derivative tetrabromobisphenol A (TBBPA) are both high production volume chemicals whose consumption has increased in recent decades due to their ubiquitous inclusion into various consumer products. BPA is a necessary component in producing polycarbonate plastic and epoxy resins, and its annual worldwide production exceeds 2.5 million metric tons . TBBPA, in comparison, is primarily used as a brominated flame retardant (BFR) in electrical and electronic equipment, with annual global demand for this chemical exceeding 120,000 metric tons (Birnbaum and Staskal, 2004) . With the inclusion of BPA into common goods such as water bottles, sports equipment, medical devices, food and beverage can lining, and thermal paper, and TBBPA into devices such as televisions, cell phones, and computers, these two chemicals have achieved a certain universality and wide reach that impacts populations worldwide. As such, both BPA and TBBPA are routinely detected in both human tissue and environmental samples (Johnson-Restrepo et al., 2008; Kang et al., 2006; Vandenberg et al., 2010; vom Saal et al., 2007) and are indeed considered universal environmental pollutants. Numerous studies prompted by these concerns have examined the toxicological effects of BPA and TBBPA; despite the current state of the science, more mechanistic research is needed to understand the potential impacts of these and similarly structured chemicals on human health.
Of all the findings regarding BPA and TBBPA, the most salient concern regarding these chemicals is their ability to disrupt endocrine signaling (Shaw et al., 2010; Vandenberg et al., 2009 ). BPA has perhaps garnered the most attention out of all endocrine disrupting chemicals (EDCs) in the scientific and lay communities. BPA is weakly estrogenic, and TBBPA structurally mimics the thyroid hormone thyroxine, but there is evidence that the actions of both This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on January 31, 2017 as DOI: 10.1124/mol.116.107342 at ASPET Journals on February 10, 2017 molpharm.aspetjournals.org Downloaded from MOL #107342 6 chemicals are not merely limited to the perturbation of the endocrine system through their respective hormone receptors (Soriano et al., 2016; Westerink, 2014) . Recent studies have shown that BPA is capable of interacting with various ionic currents, and TBBPA can alter Ca 2+ fluxes and homeostasis in cellular systems. Intracellular ionized Ca 2+ is a universal second messenger associated with myriad signaling processes that govern cell function, and BPA and TBBPA's ability to alter Ca 2+ signaling present a mode of toxicological action that could extend to numerous physiological systems, including endocrine pathways. Indeed, studies have emerged designating BPA as a cardiotoxicant due to its capacity to promote cardiac arrhythmias in isolated hearts and cardiomyocytes (Posnack et al., 2014; Yan et al., 2011) ; likewise, TBBPA has been implicated as a neurotoxicant due to Ca 2+ dysregulation in neuronal cells (Hendriks et al., 2012; Reistad et al., 2007) . These studies provided a basis for us to investigate the molecular targets of Ca 2+ dysregulation of BPA and TBBPA in a well-understood Ca 2+ signaling system, skeletal muscle excitation-contraction coupling (ECC), which has yet to be examined with these chemicals.
In skeletal muscle, Ca 2+ plays a critical role in muscular contraction initiated by a process termed ECC that conveys electrical stimuli (action potentials) on the myocyte surface (sarcolemma) to release internal Ca 2+ stored in the sarcoplasmic reticulum (SR). Two proteins essential for ECC in skeletal muscle are the dihydropyridine receptor (DHPR; Ca V 1.1) within the sarcolemma and type 1 ryanodine receptor (RyR1) within the SR. A third key protein is the sarco/endoplasmic reticulum Ca 2+ ATPase (SERCA) that mediates relaxation by actively pumping intracellular Ca 2+ back into the SR.
As an intricate Ca 2+ -mediated process involving the interplay of several critical proteins, ECC may be dysregulated through diverse means, including several mutations as well as
This article has not been copyedited and formatted. The final version may differ from this version. Preparation of total membrane fractions. Skeletal muscles were collected from the hind legs and back of 3-5 kg wild type male New Zealand White rabbits obtained from Charles River (Burlington, MA). The muscles were stored at -80°C until processed. 75 g of tissue was ground using a meat grinder and subsequently homogenized in 10 volumes of ice cold buffer (10% sucrose, 10 mM HEPES, 10 µg/mL leupeptin hydrochloride, 100 µM phenylmethanesulfonylfluoride, pH 7.4) using a blender at maximum speed for 1 min.
Homogenates were differentially centrifuged at 10,000 x g (20 min) and 110,000 x g (60 min) at 4°C to obtain total (crude) membrane fractions. The final pellets were resuspended in 10% sucrose and 10 mM HEPES, pH 7.4, and aliquoted and stored at -80°C until needed.
This article has not been copyedited and formatted. The final version may differ from this version. The SERCA inhibitor thapsigargin (TG, 1 µM) was added to the positive control to assess the non-SERCA component of ATPase activity. SERCA activity was derived from the maximum rate of NADH conversion achieved over a 1 min period, with the corresponding non-SERCA rate subtracted out. Modulation of SERCA activity by BPA or TBBPA was expressed as percentage of DMSO control. All experiments were performed at 37°C with constant stirring and using two different membrane preparations.
Preparation and culture of primary myotubes. Primary skeletal myoblasts were isolated from mixed sex wild type mouse neonates, as previously described (Rando and Blau, 1994) .
Specifically, myoblasts were cultured in 10 cm tissue culture treated dishes coated with calf skin collagen in Ham's F-10 medium supplemented with 20% (v/v) HyClone bovine growth serum (GE Healthcare Life Sciences, Logan, UT), 2 mM L-glutamine, 100 IU/mL penicillin G, 100 µg/mL streptomycin sulfate, and 4 ng/mL basic fibroblast growth factor (PeproTech, Rocky Hill, and the myoblasts were allowed to differentiate into myotubes for 3-4 d in DMEM containing
IU/mL penicillin G, and 100 µg/mL streptomycin sulfate at 37°C in 5% CO 2 /10% O 2 . and subsequently digitized using a Digidata 1440A (Molecular Devices, Sunnyvale, CA); recorded data were analyzed using pClamp 10 software suite (Molecular Devices). For each dish, five initial measurements were made in normal Tyrode's solution and an additional ten measurements were made 10 min after adding BPA (30 µM), TBBPA (10 µM), or control (0.1% DMSO) to the cells. For the initial measurements, myotubes with V m less negative than -60 mV were rejected due to potential membrane damage (<15% of myotubes). All impalements were performed on independent myotubes, and data were collected from three different culture days.
Imaging of Ca
Statistical analysis. All data are presented as mean ± SEM, and all error bars represent SEM. All best-fit EC 50 /IC 50 values are reported with corresponding 95% confidence intervals (CI). Where appropriate, comparisons were made using one-way ANOVA with Dunnett's post hoc test or two-way ANOVA with Dunnett's post hoc test. p < 0.05 was considered significant. All curvefitting (linear and nonlinear) and statistical tests were accomplished using GraphPad Prism (GraphPad Software, La Jolla, CA).
This article has not been copyedited and formatted. The final version may differ from this version. (Pessah et al., 1987) . TBBPA elicited a concentration-dependent increase in specific [ 3 H]ryanodine binding to RyR1 (EC 50 = 7.7 µM, 95% CI: 6.8-8.8 µM; Figure   1A , top), achieving 352.5 ± 12.1% and 463.6 ± 12.5% of control at 10 and 30 µM, respectively Complementary to ECC in skeletal muscle function is the relaxation process, which is mediated, among others, by SERCA, which pumps cytosolic Ca 2+ back into the SR. Using a spectrophotometric assay that couples NADH oxidation to ATP hydrolysis by SERCA, we
This article has not been copyedited and formatted. The final version may differ from this version. examined the activity of this enzyme by quantifying the rate of change in NADH absorption.
TBBPA altered SERCA activity in a non-monotonic manner (Figures 2A, 2C ). TBBPA significantly increased SERCA activity (p ≤ 0.05, one sample t test) at all concentrations tested below 10 µM, achieving 143.8 ± 7.2% of control at 6 µM, whereas the effect became inhibitory TBBPA reduced transient amplitudes by 35.6 ± 3.3% ( Figure 3 , third trace; Figure 4A ). transients rapidly extinguished after perfusion of BPA (Figure 3 , fourth and fifth traces; Figure   4A shows a composite summary for both BPA effect types). Washout of BPA rapidly restored Ca 2+ transients in a subset of cells, whereas the effects of TBBPA were invariably irreversible (data not shown).
TBBPA slowed Ca 2+ transient kinetics, nearly doubling the full-width at half-maxima of peaks at 1 µM and prolonging transient widths to 335.2 ± 34.0% of baseline after 20 min ( Figure   4B ). In contrast, 30 µM BPA did not significantly modify peak widths.
TBBPA disrupts Ca 2+ homeostasis in myotubes. To test our assertion that TBBPA alters intracellular Ca 2+ regulation in skeletal myotubes, we analyzed both the change in baseline Ca 2+ and the filling state of SR Ca 2+ stores following exposure. TBBPA concentration-dependently increased baseline Ca 2+ (to 186.9 ± 8.7% of initial baseline after 20 min at 10 µM) whereas BPA (both response types) had minimal effects on this parameter ( Figure 4C ). stores as indicated by an 82.6 ± 2.3% lower post-exposure caffeine response, whereas a much milder depletion was observed with 30 µM BPA (13.1 ± 8.2% decrease) ( Figure 4D ). Although
Depletion of SR Ca
Type II responding cells for BPA exhibited greater SR Ca 2+ content versus Type I cells, this difference was not significant (data not shown).
BPA and TBBPA modify V m in opposing directions. We explored the possibility of BPA and TBBPA altering skeletal myotube V m as an auxiliary mechanism by which these compounds impair muscle function. Measurements of membrane potential were recorded from myotubes using submicron tip microelectrodes before and after exposure to 30 µM BPA and 10 µM TBBPA, concentrations that rapidly attenuated Ca 2+ transients. Cells exposed to vehicle retained a V m of -62.1 ± 0.2 mV that was stable for at least 10 min. Treatment with BPA caused a significant hyperpolarization of V m to -67.6 ± 0.6 mV, whereas TBBPA significantly depolarized V m to -52.6 ± 0.9 mV ( Figure 4E ). Figure 5A ). Furthermore, 500 nM TBBPA This article has not been copyedited and formatted. The final version may differ from this version. significantly reduced SR Ca 2+ stores after 24 h as indicated by a 13.9 ± 3.0% smaller caffeine response versus control ( Figure 5B ).
Subacute
Interactions between TBBPA and TCS on [ 3 H]ryanodine binding. The acute effects of TBBPA observed in skeletal myotubes were reminiscent of our previous findings in myotubes with the bactericidal chemical TCS (Cherednichenko et al., 2012; Fritsch et al., 2013) . We therefore hypothesized a common mechanism for these two environmental contaminants. To test this, we 
DISCUSSION
In this present study, we investigated the effects of BPA and TBBPA on Ca 2+ dynamics and signaling in embryonic skeletal muscle and the mechanistic divergence between these two compounds afforded by their structural differences. In contrast to previous studies of the endocrine disrupting properties of BPA and TBBPA, we identify here new molecular targets within the sarcolemma and SR that impair ECC in developing skeletal muscle. Although BPA and TBBPA differ merely in bromination, only TBBPA targets proteins critical for physiological ECC, with a rank potency of DHPR>RyR1>SERCA (summarized in Figure 7 ). Nevertheless, there is a convergence with respect to these chemicals' ability to disrupt function at the cellular level. BPA's unexpected capacity to impair myotube ECC, albeit with lower potency than TBBPA, appears to be related to cell hyperpolarization that dampens membrane excitability absent of any interactions with DHPR, RyR1, and SERCA.
TBBPA's ability to enhance RyR1 activity and inhibit SERCA has broad implications on skeletal muscle function since these two actions result in a feed-forward manner to shift Ca 2+ from SR stores into the sarcoplasm that quickly results in ECC failure ( Figures 4C, 4D ). This elevation of resting [Ca 2+ ] i is not only implicated in muscle fatigue (Verburg et al., 2006) shown to impair skeletal ECC through interactions with RyR1 (Cherednichenko et al., 2012) .
The modification by TCS on the efficacy of TBBPA on [ 3 H]ryanodine binding ( Figure 6 ) strongly suggests a non-competitive interaction between these two structurally-related highvolume chemicals when engaging RyR1, arising perhaps from mutually exclusive binding sites that allosterically modify channel activity.
Previous studies have also reported TBBPA to have inhibitory effects on SERCA in skeletal muscle preparations (Ogunbayo et al., 2008; Ogunbayo and Michelangeli, 2007) but with higher potency than our findings (1.2-1.7 µM vs 13.3 µM); this discrepancy may be attributed to variations in lipid content that can alter the bioavailability of TBBPA through adsorption. The lack of activity of BPA on SERCA activity is consistent with a previous report in skeletal muscle microsomes (Woeste et al., 2013) yet contradicts a submicromolar potency finding using rat testis microsomes (Hughes et al., 2000) . This could be explained by expressional differences in SERCA such that SERCA1a, the dominant isoform in fast twitch muscle, may either be more resistant per se or compensated through higher expression density when compared to the isoform(s) in non-muscle cells (Periasamy and Kalyanasundaram, 2007) .
The SERCA-activating effect of TBBPA <10 µM in the presence of ionophore may suggest cross-talk between SERCA and RyR1 as previously posited (Gilchrist et al., 2003) .
Beyond the SR, it is evident that TBBPA has additional targets in the sarcolemma, as demonstrated by its displacement of [ 3 H]PN200 from DHPR. Although not a functional assessment of L-type Ca 2+ current, it is reasonable to believe that this potent interaction at the dihydropyridine binding site translates to a loss of Ca 2+ current mediated by DHPR (Zamponi et al., 2015) . Finally, the depolarization induced by TBBPA suggests target(s) on the sarcolemma that determine resting V m , such as K + or Cl -channels, either through direct interactions or Ca 2+ -This article has not been copyedited and formatted. The final version may differ from this version. The involvement of RyR in BPA-induced Ca 2+ dysregulation has previously been determined in murine cardiomyocytes, although involving downstream influences of estrogen receptor signaling (Gao et al., 2013; Yan et al., 2011) . However, the contribution of nonestrogenic pathways in BPA's impairment of ECC cannot be discounted considering our radioligand binding findings with BPA. Although mild, the significant increase in specific and T-type channels (Deutschmann et al., 2013; Michaela et al., 2014; Pandey and Deshpande, 2012; Wang et al., 2013) . One or more of these mechanisms could account for how BPA impairs ECC in myotubes leading to a Type II loss of function and is consistent with the hyperpolarizing influence of BPA observed in the current investigation.
Although our findings illustrate a mechanism of muscle impairment independent of endocrine-related signaling pathways, further engagement of estrogen and thyroid receptor pathways by BPA and TBBPA, respectively, present a feed-forward mechanism that can exacerbate skeletal muscle dysfunction. Both estrogen and thyroid receptors have been shown to This article has not been copyedited and formatted. The final version may differ from this version. be critical players in, among other things, glucose homeostasis and repair processes in skeletal muscle (Barros and Gustafsson, 2011; Enns and Tiidus, 2010; Salvatore et al., 2014) . Since skeletal muscle is a well-perfused organ that constitutes 30-40% of body mass in humans, dysregulation of these fundamental processes can have far-reaching consequences throughout the entire body. Concurrent engagement of endocrine and non-endocrine pathways by exogenous chemicals such as BPA and TBBPA can therefore produce mutually destabilizing effects that ultimately compromise the function and health of muscle.
Knowledge gained from our study ultimately serves two ends: 1) to understand the structural requisites for forming molecular interactions with proteins critical for skeletal muscle (Calafat et al., 2009; Calafat et al., 2008) . These findings of elevated TBBPA and BPA concentrations in newborns harmonize with our use of an embryonic form of primary skeletal muscle for assessing Ca 2+ dysregulation. The loss of muscle strength and tone, as predicted by our myotube model, not only affects mobility and movement but-of particular importance to the developing infant-can produce more enduring effects by perturbing transcriptional pathways innately regulated by [Ca 2+ ] i that are necessary for, among others, myogenesis (Gundersen, 2011) . In extreme cases, neonatal hypotonia resultant of disorders such as muscular dystrophy can impair feeding and respiration as well as cause muscle wasting (Emery, 2002; Sparks, 2015) . More work is needed to determine if prolonged exposures to BPA and TBBPA can lead to similar detriments to muscle and developmental physiology in the whole organism.
In this study, we demonstrate for the first time the deleterious effects of BPA and TBBPA exposure on skeletal muscle function. Exposure to both chemicals is toxicologically relevant and concerning due to their high production volume and ubiquitous inclusion into consumer products worldwide. Our findings add to the growing knowledge base on the chemistry of RyR1 modulation while ultimately linking TBBPA to other tissue toxicities through a common mechanism of DHPR, RyR, and SERCA dysregulation. Furthermore, that BPA impairs skeletal muscle function without engaging these molecular targets implies a distinct mechanism of action that may involve instead the modulation of cellular excitability. Understanding the spectrum of targets of BPA and TBBPA is critical for derisking these ubiquitous chemicals and limiting toxic, and especially chronic, exposures. As newer alternatives are developed to replace these compounds (Ezechias et al., 2014; Rosenmai et al., 2014) , it is paramount to scrutinize the structural properties of these replacements to ensure that they are safe for everyday consumer use.
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